Intrinsiqq
Earth Science Tech Inc. logo

Earth Science Tech Inc. Insider Trading

ETST

⊜ Compare
Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in Jul 2025.

Net open-market
$0
0 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
0 / 0
executives and directors
Last open-market buy
Jul 2025
Jul 22, 2025

Get an email when ETST's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Jul 22, 2025
    Giorgio R. Saumat
    CEO · bought 50,000 at $0.21
    11K
    <0.1% of stake
  • Jul 21, 2025
    Giorgio R. Saumat
    CEO · bought 100,000 at $0.20
    20K
    <0.1% of stake
  • Jul 8, 2025 – Jul 9, 2025
    Yovan Arturo Sanchez
    Director · bought 33,044 at avg $0.18
    6K
    2.0% of stake
  • Jul 2, 2025
    Yovan Arturo Sanchez
    Director · bought 60,805 at $0.20
    12K
    3.8% of stake
  • Mar 14, 2025
    Yovan Arturo Sanchez
    Director · bought 100,000 at $0.12
    12K
    6.6% of stake
  • Mar 10, 2025
    Mario Guillermo Tabraue
    COO · bought 40,000 at $0.14
    6K
    0.3% of stake
  • Mar 4, 2025
    Christopher Alan Rose
    CTO · bought 31,500 at avg $0.16
    5K
    59% of stake
  • Feb 24, 2025
    Giorgio R. Saumat
    CEO · bought 100,000 at $0.18
    18K
    <0.1% of stake
  • Jan 31, 2025
    Yovan Arturo Sanchez
    Director · bought 100,000 at $0.18
    18K
    7.1% of stake
  • Jan 28, 2025
    Ernesto L Flores
    CFO · bought 43,478 at $0.23
    10K
    84% of stake
  • Jan 24, 2025
    Mario Guillermo Tabraue
    COO · bought 20,000 at $0.23
    5K
    0.2% of stake
  • Dec 27, 2024 – Jan 16, 2025
    Giorgio R. Saumat
    CEO · bought 787,500 at avg $0.20
    156K
    0.6% of stake
  • Jan 8, 2025
    Jeff P. H. Cazeau
    Other · bought 72,555 at avg $0.15
    11K
    29% of stake
  • Jan 7, 2025
    Jeff P. H. Cazeau
    Other · bought 79,200 at $0.12
    10K
    47% of stake
  • Jan 2, 2025
    Yovan Arturo Sanchez
    Director · bought 56,151 at $0.12
    7K
    4.2% of stake
  • Dec 12, 2024
    Yovan Arturo Sanchez
    Director · bought 100,000 at $0.12
    12K
    8.0% of stake
  • Nov 27, 2024
    Giorgio R. Saumat
    CEO · bought 104,999 at avg $0.15
    16K
    <0.1% of stake
  • Nov 20, 2024
    Giorgio R. Saumat
    CEO · bought 75,102 at avg $0.17
    13K
    <0.1% of stake
  • Nov 19, 2024
    Giorgio R. Saumat
    CEO · bought 195,844 at avg $0.15
    30K
    0.2% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ETST, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with ETST

CompareIntrinsic value
SBFMSunshine Biopharma Inc.
$2.65-3.28%40
LIFDLftd Partners Inc.
$0.11+0.00%35
FHTXFoghorn Therapeutics Inc.
$2.10-1.41%40
NRIXNurix Therapeutics Inc.
$15.95-38.23%84
VTVTvTv Therapeutics Inc.
$24.03+2.04%40
ZOMDFZomedica Corp.
$0.09-1.08%46
ZYMEZymeworks Inc.
$30.98+2.82%10
CUECue Biopharma, Inc.
$19.84-4.89%40

Spot a number that looks wrong? Check it in ETST's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ETST

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.